1. Adalimumab-related alopecia in a patient affected by psoriasis
- Author
-
Montse Salleras Redonnet, Pablo Umbert Millet, Gemma Melé-Ninot, Maribel Iglesias Sancho, Vicente Expósito-Serrano, Mònica Quintana Codina, and M. Sánchez-Regaña
- Subjects
Male ,Pathology ,medicine.medical_specialty ,Necrosis ,Alopecia Areata ,Side effect ,Biopsy ,Anti-Inflammatory Agents ,Dermatology ,anti-TNF, adalimumab, alopecia areata, psoriasis, psoriatic alopecia ,Diagnosis, Differential ,Psoriasis ,medicine ,Adalimumab ,Humans ,skin and connective tissue diseases ,Scalp ,medicine.diagnostic_test ,integumentary system ,business.industry ,Alopecia ,Histology ,General Medicine ,Middle Aged ,Alopecia areata ,medicine.disease ,medicine.anatomical_structure ,medicine.symptom ,business ,medicine.drug - Abstract
Alopecia induced by biological therapy is a rare side effect of this type of drugs. A total of 23 patients of psoriasiform eruptions with severe scalp involvement that induced alopecia during anti-tumor necrosis factor (anti-TNF) treatment of non-dermatological conditions have been previously reported. We present a 50-year-old man affected by plaque psoriasis that developed psoriasiform patches with alopecia over his scalp 10 months after initiating treatment with adalimumab. Punch biopsy of the alopecic area on the scalp revealed psoriasiform epidermal changes and alopecia areata-like dermal changes. Along with these findings, there was a dermal inflammatory infiltrate made up of eosinophils and plasma cells. In conclusion, scalp psoriasiform lesions with alopecia in patients treated with anti-TNF agents have been rarely reported. We describe a patient with anti-TNF therapy-related alopecia affected by psoriasis. Our patient has a peculiar histology with features of psoriasis and alopecia areata in addition to eosinophils and plasma cells. This entity may respond to topical treatment. However in patients of severe scalp involvement anti-TNF suspension should be considered.
- Published
- 2017